Press Releases

Mediclinic Intnl plc - 2018 Capital Markets Day

RNS Number : 8157S
Mediclinic International plc
28 June 2018

Mediclinic International plc

(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP


LEI: 2138002S5BSBIZTD5I60

("Mediclinic", the "Company" or the "Group")


28 June 2018


2018 Capital Markets Day


Mediclinic International plc, the international private healthcare services group, will today host a Capital Markets Day event and site visit for analysts and investors in Zurich, Switzerland. No new material information will be provided during the event and guidance remains unchanged with trading in line with expectations.


The event will be available via a live webcast at 08:00BST/09:00CEST, details of which can be found below.


The event will include presentations from the Group's CEO and CFO in addition to operational reviews from the divisional CEO's of Hirslanden, Mediclinic Southern Africa and Mediclinic Middle East.


The key theme for the day is Mediclinic's tailored approach to value creation focusing on:

·     Our diversified international presence and unified focus

·     Strong healthcare market potential

·     Our unique approach to creating value putting patients at the core of our business

·     Our focus on international growth opportunities

·     Our management skills and expertise

·     Financial discipline across the Group


Webcast details

A live webcast of today's presentations along with the agenda and supporting material can be accessed via the Group's Investor Relations website. Please register for the event, which starts at 08:00 BST/09:00 CEST, via the following link:


A replay facility will be available on the website from Friday 29 June 2018.


About Mediclinic International plc

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with current operating divisions in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-listed and UK-based private healthcare group.


As at the date of this announcement, Mediclinic comprises 75 hospitals and 28 outpatient clinics. Hirslanden operates 17 private hospitals and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 22 clinics with more than 700 inpatient beds in the United Arab Emirates.


Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia.


For further information, please contact:


Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

+44 (0)20 3786 8181


Media queries

FTI Consulting

Brett Pollard/Debbie Scott - UK

+44 (0)20 3727 1000

Sherryn Schooling - South Africa

+27 (0)21 487 9000


Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom


Corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit